Bay 55-9837 structure
|
Common Name | Bay 55-9837 | ||
|---|---|---|---|---|
| CAS Number | 463930-25-8 | Molecular Weight | 3742.25000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C148H239ClN44O42 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Bay 55-9837Bay 55-9837 is a potent and highly selective agonist of VPAC2, with a Kd of 0.65 nM. Bay 55-9837 may be a useful therapy for the research of type 2 diabetes[1]. |
| Name | unii-sqd60kz8rj |
|---|---|
| Synonym | More Synonyms |
| Description | Bay 55-9837 is a potent and highly selective agonist of VPAC2, with a Kd of 0.65 nM. Bay 55-9837 may be a useful therapy for the research of type 2 diabetes[1]. |
|---|---|
| Related Catalog | |
| Target |
Kd: 0.65 nM (VPAC2)[1] |
| References |
| Molecular Formula | C148H239ClN44O42 |
|---|---|
| Molecular Weight | 3742.25000 |
| Exact Mass | 3740.04000 |
| PSA | 1675.16000 |
| LogP | 5.32170 |
| InChIKey | NHMJBXFCQMBYCP-ZBLLYJRDSA-N |
| SMILES | CCC(C)C(NC(=O)C(CO)NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)O)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(N)Cc1c[nH]cn1)C(C)C)C(C)O)C(C)O)C(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(N)=O)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(N)=O |
| BAY-55-9837 |
| His-ser-asp-ala-val-phe-thr-asp-asn-tyr-thr-arg-leu-arg-lys-gln-val-ala-ala-lys-lys-tyr-leu-gln-ser-ile-lys-asp-lys-arg-tyr-NH2 |